Nizatidine
7 NDCs across 4 manufacturers|7 Generic,0 Brand
Nizatidine is used to treat duodenal ulcer, dyspepsia, peptic esophagitis, gastroesophageal reflux, heartburn and helicobacter infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 12, 1988, and the first generic was approved Jul 5, 2002. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $417K on Nizatidine across 4,084 claims for 1,378 beneficiaries.
Nizatidine is available as 7 NDCs from 4 manufacturers (7 generic, 0 brand), with NADAC prices from $0.24 to $0.80 per EA — the most expensive product costs about 3.4× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
7G / 0B
Manufacturers
4
competing in market
Price Spread
$0.24 – $0.80
per EA, 6 of 7 NDCs
7d Activity
avg -0.1% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Dr. Reddy's Laboratories Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Histamine-2 Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing NIZATIDINE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
NIZATIDINE 15 MG/ML SOLUTION | $1.0084 per ML | — |
NIZATIDINE 150 MG CAPSULE | $0.8042 per EA | -0.13% |
NIZATIDINE 150 MG CAPSULE | $0.8042 per EA | -0.13% |
NIZATIDINE 300 MG CAPSULE | $0.7988 per EA | — |
NIZATIDINE 300 MG CAPSULE | $0.5821 per EA | — |
NIZATIDINE 150 MG CAPSULE | $0.2441 per EA | — |
NIZATIDINE 150 MG CAPSULE | $0.2352 per EA | — |
Frequently Asked Questions
What is Nizatidine used to treat?
Nizatidine is used to treat duodenal ulcer, dyspepsia, peptic esophagitis, gastroesophageal reflux, heartburn and helicobacter infections, per the National Library of Medicine's MED-RT classification.
When did Nizatidine become available as a generic?
FDA approved the first generic Nizatidine (ANDA) on Jul 5, 2002. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Nizatidine?
In 2024, Medicare Part D spent $417K on Nizatidine across 4,084 claims for 1,378 beneficiaries.
How many Nizatidine products are on the market?
The Nizatidine drug market contains 7 NDCs from 4 manufacturers — 7 generic and 0 brand products.
What is the price range for Nizatidine?
NADAC reference prices for Nizatidine range from $0.2352 to $0.8042 per EA — the most expensive product costs about 3.4× the cheapest. 1 additional product is priced per a different unit (e.g. liquids per ML) and isn't directly comparable.
Which manufacturers make Nizatidine?
4 manufacturers list Nizatidine in NADAC. Ranked by number of NDCs, the largest are Dr. Reddy's Laboratories Inc. (3), Actavis Pharma, Inc. (2), Amneal Pharmaceuticals LLC (1), Epic Pharma LLC (1).
How has the price of Nizatidine changed recently?
Over the past 7 days, 0 Nizatidine NDCs rose and 2 fell, with a market-wide average change of -0.1%.